Mary Dooley
Patrimonio netto: 8 666 $ in data 31/05/2026
Patrimonio netto: 8 666 $ in data 31/05/2026
Mary Beth Dooley is currently Chief Executive & Financial Officer at Synlogic, Inc., a position starting in 2025.
Formerly, Ms. Dooley was Senior Manager-Financial Planning Analysis at Idera Pharmaceuticals, Inc. from 2014 to 2018 and Assistant Vice President at Boston Private Bank & Trust Co. from 2005 to 2011.
Education includes undergraduate studies at Bates College and graduate studies including an MBA at Northeastern University.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
SYNLOGIC INC 0,11% | 31/03/2026 | 12.744 ( 0,11% ) | 8 666 $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| SYNLOGIC, INC. | Amministratore Delegato | 01/01/2025 |
| Società | Posizione | Fine |
|---|---|---|
Idera Pharmaceuticals, Inc.
Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops drug candidates for oncology and rare disease indications | Corporate Officer/Principal | 01/05/2018 |
Boston Private Bank & Trust Co.
Boston Private Bank & Trust Co. Regional BanksFinance Provides banking and wealth management services | Corporate Officer/Principal | 01/05/2011 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 5 |
|---|---|
Idera Pharmaceuticals, Inc.
Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops drug candidates for oncology and rare disease indications | Health Technology |
Boston Private Bank & Trust Co.
Boston Private Bank & Trust Co. Regional BanksFinance Provides banking and wealth management services | Finance |
Bates College
Bates College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Northeastern University
Northeastern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Synlogic, Inc.
Synlogic, Inc. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale